Skip to content
Clinical Trials – home

University Multiprofile Hospital For Active Treatment St. Ivan Rilski EAD

Verified siteinfo

Bulgaria Boulevard Akademik Ivan Evstratiev Geshov 15, 1431 Sofia, Bulgaria

  • 33 trials recruiting
  • Systemic lupus erythematosus · Chronic lymphocytic leukaemia · Colitis ulcerative
  • Adults and children

About Specializations

University Multiprofile Hospital For Active Treatment St. Ivan Rilski EAD in Sofia, Bulgaria specialises in clinical trials of conditions such as Systemic lupus erythematosus, Chronic lymphocytic leukaemia, Colitis ulcerative, Relapsing multiple sclerosis, and other specialisations. This site conducts important research.

Main research areas of the site

Analytical, Diagnostic and Therapeutic Techniques and Equipment

At University Multiprofile Hospital For Active Treatment St. Ivan Rilski EAD in Sofia, research in diagnostic imaging focuses on improving the performance and safety of magnetic resonance imaging contrast agents. These studies are designed to support better detection of central nervous system and non-central nervous system conditions, while also expanding knowledge in pediatric imaging.

  • Evaluating new contrast enhancement approaches for MRI-based diagnosis
  • Studying imaging support for central nervous system pathology and other body regions
  • Assessing how contrast agents perform in children undergoing CE-MRI

The overall aim is to test whether newer imaging agents can match or improve the effectiveness of established options while maintaining a strong safety profile.

Musculoskeletal Diseases

Clinical research in musculoskeletal diseases at this site includes work on psoriatic arthritis, with a focus on finding better ways to control symptoms and improve patient outcomes. This area reflects the hospital’s broader interest in both treatment effectiveness and patient-centered care.

  • Testing a new therapy for psoriatic arthritis
  • Measuring improvement in joint and inflammation-related symptoms
  • Comparing treatment benefit against placebo to understand effectiveness

These trials aim to determine whether emerging treatments can offer meaningful relief for people living with inflammatory joint disease.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Boulevard Akademik Ivan Evstratiev Geshov 151431 SofiaBulgaria
Recruiting now
33 trials
Conditions studied
74
Partner status
Verified site

More sites in SofiaBulgaria

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

109 clinical trials

Phase 2 Study of Nemolizumab for Skin Thickening in Adults with Systemic Sclerosis

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Nemolizumab
  • Sponsor:Galderma S.A.

BI 3000202 in Patients with Moderate to Severe Systemic Lupus Erythematosus

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Sponsor:Boehringer Ingelheim Espana S.A.

Obesity+2

Recruiting

A study to evaluate the effects of zenagamtide on weight and pain in patients with overweight or obesity and knee osteoarthritis

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:POLYPEPTIDE CONSISTING OF A GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST AND AN AMYLIN RECEPTOR AGONIST, CONNECTED BY A LINKER WITH 4 GLYCINE RESIDUES, AND CONNECTED TO A C18 FATTY ACID SIDE CHAIN
  • Sponsor:Novo Nordisk A/S

Obesity+2

Recruiting

A study to evaluate the efficacy and safety of zenagamtide in people with overweight or obesity and knee osteoarthritis

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:POLYPEPTIDE CONSISTING OF A GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST AND AN AMYLIN RECEPTOR AGONIST, CONNECTED BY A LINKER WITH 4 GLYCINE RESIDUES, AND CONNECTED TO A C18 FATTY ACID SIDE CHAIN
  • Sponsor:Novo Nordisk A/S

A Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH

A Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH

Study on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Tozorakimab
  • Sponsor:AstraZeneca AB

Study on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Emtricitabine
  • Sponsor:Novartis Pharma AG

Efficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International

Nipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Nipocalimab
  • Sponsor:Janssen Cilag International

Long-Term Safety Study of Asciminib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bosutinib
  • Sponsor:Novartis Pharma AG

A study to evaluate the effectiveness and safety of AZD1163 in adults with moderate to severe rheumatoid arthritis

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:AZD1163
  • Sponsor:AstraZeneca AB
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.